The first human results with 123I MIP-1072 and MIP-1095 show rapid accumulation and prolonged retention in PSMA-expressing lesions, with tumour/background ratios of ∼10 achieved in SPECT images obtained 4 h after injection 9. The gene discussed is FOLH1; the disease is neoplasm.